Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02626624 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the CarboClear Pedicle Screw System
A NA study of Degenerative Disc Disease and Spondylolisthesis, Grade 1, sponsored by CarboFix Orthopedics.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 8
- Study locations
NCT02626624 is a NA study of Degenerative Disc Disease and Spondylolisthesis, Grade 1 that has completed, run by CarboFix Orthopedics. The registered enrollment target is 57 participants, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (66% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT02626624, a NA study of Degenerative Disc Disease and Spondylolisthesis, Grade 1, has completed, sponsored by CarboFix Orthopedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this trial is to demonstrate the safety and effectiveness of the CarboClear Pedicle Screw System, for skeletally mature DDD patients undergoing one level spinal fusion in combination with interbody fusion device, and requiring immediate, rigid, posterior spinal stabilization of the lumbar and/or sacral spine.
Conditions Studied
Interventions
- DEVICE Implantation of the CarboClear Pedicle Screw System
Study Locations (8)
Other
- Herzliya Medical Center - Herzliya
- Meir Medical Center - Kfar Saba
- Assuta Medical Center - Israel Spine Center - Tel Aviv
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
New York
- The Brooklyn Hospital - Brooklyn
Ohio
- Crystal Clinic Orthopaedic Center - Akron
Texas
- St. David's Round Rock Medical Center - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2015-12-27 |
| Est. Completion | 2022-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02626624
The ClinicalTrials.gov registry entry for NCT02626624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (66% lower). The listed sponsor is CarboFix Orthopedics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Implantation of the CarboClear Pedicle Screw System is the first listed.
NCT02626624 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Other, Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02626624 about?
NCT02626624 is a clinical study titled "Safety and Efficacy of the CarboClear Pedicle Screw System". The purpose of this trial is to demonstrate the safety and effectiveness of the CarboClear Pedicle Screw System, for skeletally mature DDD patients undergoing one level spinal fusion in combination with interbody fusion device, and requiring immediate, rigid, posterior spinal stabilization of the lu...
What is the current status of trial NCT02626624?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2015-12-27. Estimated completion is 2022-12-28.
What conditions does trial NCT02626624 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Spondylolisthesis, Grade 1.
What interventions are being tested in trial NCT02626624?
The interventions under investigation include: Implantation of the CarboClear Pedicle Screw System (DEVICE).
Who is sponsoring clinical trial NCT02626624?
This trial is sponsored by CarboFix Orthopedics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02626624 being conducted?
This trial has 8 study locations across Massachusetts, Minnesota, New York, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
-
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
RECRUITING · NA
-
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
RECRUITING · NA
-
ACDF Using Structural Allograft vs. Tritanium C
RECRUITING · NA
Explore more on PlainTrial
Degenerative Disc Disease
All registered trials for this condition
Spondylolisthesis, Grade 1
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.